Phosphatidylinositol 4,5-bisphosphate is a novel coactivator of the pseudomonas aeruginosa cytotoxin exoU

Infection and Immunity

Volumn 81, Issue 8, 2013, Pages 2873-2881

  Tyson, Gregory H ^a   Hauser, Alan R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CYTOTOXIN; EXOU PROTEIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; CELL LYSATE; CYTOSOLIC FRACTION; EXOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA;

BACTERIAL PROTEINS; COENZYMES; ENZYME ACTIVATION; IMMUNOBLOTTING; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84880654391     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00414-13     Document Type: Article

References (40)

1. Lister PD, Wolter DJ, Hanson ND. 2009. Antibacterial-resistant Pseu-domonas aeruginosa: clinical impact and complex regulation of chromo-somally encoded resistance mechanisms. Clin. Microbiol. Rev. 22:582-610.
2. Hauser AR, Cobb E, Bodi M, Mariscal D, Valles J, Engel JN, Rello J. 2002. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia causedbyPseudomonas aeruginosa. Crit. Care Med. 30:521-528.
3. Shaver CM, Hauser AR. 2004. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoTtovirulence inthe lung. Infect. Immun. 72:6969-6977.
4. Hauser AR. 2009. The type III secretion system of Pseudomonas aerugi-nosa: infection by injection. Nat. Rev. Microbiol. 7:654-665.
5. Barbieri JT, Sun J. 2004. Pseudomonas aeruginosa ExoS and ExoT. Rev. Physiol. Biochem. Pharmacol. 152:79-92.
6. Fu H, Coburn J, Collier RJ. 1993. The eukaryotic host factor that activates exoenzyme S of Pseudomonas aeruginosa is a member of the 14-3-3 protein family. Proc. Natl. Acad. Sci. U. S. A. 90:2320-2324.
7. Yahr TL, Vallis AJ, Hancock MK, Barbieri JT, Frank DW. 1998. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc. Natl. Acad. Sci. U. S. A. 95:13899-13904.
8. Finck-Barbancon V, Goranson J, Zhu L, Sawa T, WienerKronish JP, Fleiszig SMJ, Wu C, MendeMueller L, Frank DW. 1997. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol. Microbiol. 25:547-557.
9. Hauser AR, Kang PJ, Engel JN. 1998. PepA, a secreted protein of Pseu-domonas aeruginosa, is necessary for cytotoxicity and virulence. Mol. Mi-crobiol. 27:807-818.
10. Miyata S, Casey M, Frank DW, Ausubel FM, Drenkard E. 2003. Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system inPseudomonas aeruginosa pathogenesis. Infect. Immun. 71:2404-2413.
11. Schulert GS, Feltman H, Rabin SD, Martin CG, Battle SE, Rello J, Hauser AR. 2003. Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia. J. Infect. Dis. 188:1695-1706.
12. Gendrin C, Contreras-Martel C, Bouillot S, Elsen S, Lemaire D, Skou-fias DA, Huber P, Attree I, Dessen A. 2012. Structural basis of cytotox-icity mediated by the type III secretion toxin ExoU from Pseudomonas aeruginosa. PLoS Pathog. 8:e1002637. doi: 10.1371/journal.ppat.1002637.
13. Halavaty AS, Borek D, Tyson GH, Veesenmeyer JL, Shuvalova L, Minasov G, Otwinowski Z, Hauser AR, Anderson WF. 2012. Structure of the type III secretion effector protein ExoU in complex with its chap-erone SpcU. PLoS One 7:e49388. doi: 10.1371/journal.pone.0049388.
14. Sato H, Feix JB, Hillard CJ, Frank DW. 2005. Characterization of phospholipase activity of the Pseudomonas aeruginosa type III cytotoxin, ExoU. J. Bacteriol. 187:1192-1195.
15. Sato H, Frank DW, Hillard CJ, Feix JB, Pankhaniya RR, Moriyama K, Finck-Barbancon V, Buchaklian A, Lei M, Long RM, Wiener-Kronish J, Sawa T. 2003. The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J. 22:2959-2969.
16. Rabin SD, Veesenmeyer JL, Bieging KT, Hauser AR. 2006. A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells. Infect. Immun. 74:2552-2561.
17. Rabin SD, Hauser AR. 2005. Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU. Infect. Immun. 73:573-582.
18. Schmalzer KM, Benson MA, Frank DW. 2010. Activation of ExoU phospholipase activity requires specific C-terminal regions. J. Bacteriol. 192:1801-1812.
19. Veesenmeyer JL, Howell H, Halavaty AS, Ahrens S, Anderson WF, Hauser AR. 2010. Role of the membrane localization domain of the Pseu-domonas aeruginosa effector protein ExoU in cytotoxicity. Infect. Im-mun. 78:3346-3357.
20. Sato H, Feix JB, Frank DW. 2006. Identification of superoxide dismutase as a cofactor for the Pseudomonas type III toxin, ExoU. Biochemistry 45:10368-10375.
21. Anderson DM, Schmalzer KM, Sato H, Casey M, Terhune SS, Haas AL, Feix JB, Frank DW. 2011. Ubiquitin and ubiquitin-modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU. Mol. Micro-biol. 82:1454-1467.
22. Rabin SDP, Hauser AR. 2003. Pseudomonas aeruginosa ExoU, a toxin transported by the type III secretion system, kills Saccharomyces cerevi-siae. Infect. Immun. 71:4144-4150.
23. Gietz RD, Schiestl RH. 2007. High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method. Nat. Protoc. 2:31-34.
24. Stirling FR, Cuzick A, Kelly SM, Oxley D, Evans TJ. 2006. Eukaryotic localization, activation and ubiquitinylation of a bacterial type III secreted toxin. Cell Microbiol. 8:1294-1309.
25. McLaughlin S, Wang J, Gambhir A, Murray D. 2002. PIP(2) and proteins: interactions, organization, and information flow. Annu. Rev. Bio-phys. Biomol. Struct. 31:151-175.
26. Ferrell JE, Jr, Huestis WH. 1984. Phosphoinositide metabolism and the morphology of human erythrocytes. J. Cell Biol. 98:1992-1998.
27. Martin TF. 2001. PI(4,5)P(2) regulation of surface membrane traffic. Curr. Opin. Cell Biol. 13:493-499.
28. Payrastre B, Missy K, Giuriato S, Bodin S, Plantavid M, Gratacap M. 2001. Phosphoinositides: key players in cell signalling, in time and space. Cell Signal. 13:377-387.
29. Simonsen A, Wurmser AE, Emr SD, Stenmark H. 2001. The role of phosphoinositides in membrane transport. Curr. Opin. Cell Biol. 13:485-492.
30. Di Paolo G, De Camilli P. 2006. Phosphoinositides in cell regulation and membrane dynamics. Nature 443:651-657.
31. Strahl T, Thorner J. 2007. Synthesis and function of membrane phos-phoinositides in budding yeast, Saccharomyces cerevisiae. Biochim. Bio-phys. Acta 1771:353-404.
32. Stefan CJ, Audhya A, Emr SD. 2002. The yeast synaptojanin-like proteins control the cellular distribution of phosphatidylinositol (4,5)-bisphosphate. Mol. Biol. Cell 13:542-557.
33. Pizarro-Cerda J, Cossart P. 2004. Subversion of phosphoinositide metabolism by intracellular bacterial pathogens. Nat. Cell Biol. 6:1026-1033.
34. Niebuhr K, Giuriato S, Pedron T, Philpott DJ, Gaits F, Sable J, Sheetz MP, Parsot C, Sansonetti PJ, Payrastre B. 2002. Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S. flexneri effector IpgD reorganizes host cell morphology. EMBO J. 21:5069-5078.
35. Ireton K, Payrastre B, Chap H, Ogawa W, Sakaue H, Kasuga M, Cossart P. 1996. A role for phosphoinositide 3-kinase in bacterial invasion. Science 274:780-782.
36. Celli J, Olivier M, Finlay BB. 2001. Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways. EMBO J. 20:1245-1258.
37. Katan M, Williams RL. 1997. Phosphoinositide-specific phospholipase C: structural basis for catalysis and regulatory interactions. Semin. Cell Dev. Biol. 8:287-296.
38. Le Berre L, Takano T, Papillon J, Lemay S, Cybulsky AV. 2006. Role of phosphatidylinositol 4,5-bisphosphate in the activation of cytosolic phos-pholipase A2-alpha. Prostaglandins Other Lipid Mediators 81:113-125.
39. Min DS, Park SK, Exton JH. 1998. Characterization of a rat brain phos-pholipase D isozyme. J. Biol. Chem. 273:7044-7051.
40. Phillips RM, Six DA, Dennis EA, Ghosh P. 2003. In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors. J. Biol. Chem. 278: 41326-41332.